SPRO · Spero Therapeutics, Inc. · Investor Relations
Market Cap
$71.63M
Shares
58.23M
Volume · Oct 5
942.72K
Avg daily vol (3M)
1.19M
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-09-15 | H.C. Wainwright 28th Annual Global Investment Conference | Conference |
| 2026-08-12 | Spero Therapeutics Second Quarter 2026 Financial Results Business Update | Earnings call |
| 2026-06-23 | Spero Therapeutics 2026 Annual Meeting | Shareholder meeting |
| 2026-05-13 | Spero Therapeutics to Report First Quarter 2026 Financial Results and Provide Business Update | Results publication |
| 2026-03-26 | Spero Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update | Results publication |
| 2025-11-13 | Spero Therapeutics to Report Third Quarter 2025 Financial Results and Provide Business Update | Results publication |
| 2025-10-19 | Spero Therapeutics Announces Presentations on Tebipenem Hbr at IDWeek | Presentation |